SCM
Silverarc Capital Management Portfolio holdings
AUM
$489M
This Quarter Return
-3.38%
1 Year Return
+71.55%
3 Year Return
+1,109.63%
5 Year Return
–
10 Year Return
–
AUM
$213M
AUM Growth
+$213M
(+100,917%)
Cap. Flow
+$58.2M
Cap. Flow
% of AUM
27.29%
Top 10 Holdings %
Top 10 Hldgs %
50.55%
Holding
88
New
13
Increased
29
Reduced
15
Closed
19
Top Buys
| 1 |
MORF
Morphic Holding, Inc. Common Stock
MORF
|
$7.59M |
| 2 |
Veracyte
VCYT
|
$5.84M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$5.28M |
| 4 |
Oric Pharmaceuticals
ORIC
|
$4.85M |
| 5 |
Xenon Pharmaceuticals
XENE
|
$4M |
Top Sells
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$11.1M |
| 2 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
$5.19M |
| 3 |
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
|
$1.44M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
$1.03M |
| 5 |
Immatics
IMTX
|
$786K |
Sector Composition
| 1 | Healthcare | 98.78% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Regenxbio
RGNX
$498M
| $2.57M | 0.79% |
+104,129
| New | +$2.57M |
|
27
Akero Therapeutics
AKRO
$3.65B
| $2.46M | 0.76% |
+260,325
| New | +$2.46M |
|
|
MRTX
28
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $2.44M | 0.75% |
36,403
-9,719
| -21% | -$653K |
|
|
OTIC
29
DELISTED
Otonomy, Inc.
OTIC
| $2.17M | 0.67% |
1,041,273
-166,112
| -14% | -$346K |
|
|
CLYM
30
Climb Bio, Inc. Common Stock
CLYM
$165M
| $2.15M | 0.66% |
713,009
+624,730
| +708% | +$1.89M |
|
31
Syndax Pharmaceuticals
SNDX
$1.39B
| $2.08M | 0.64% |
107,852
+6,405
| +6% | +$123K |
|
32
Phreesia
PHR
$1.81B
| $1.95M | 0.6% |
+78,111
| New | +$1.95M |
|
|
VRAY
33
DELISTED
ViewRay, Inc.
VRAY
| $1.94M | 0.6% |
732,740
+296,644
| +68% | +$786K |
|
34
Day One Biopharmaceuticals
DAWN
$766M
| $1.89M | 0.58% |
+105,476
| New | +$1.89M |
|
|
IMGN
35
DELISTED
Immunogen Inc
IMGN
| $1.87M | 0.58% |
416,479
-228,521
| -35% | -$1.03M |
|
36
CVRx
CVRX
$204M
| $1.76M | 0.54% |
+292,145
| New | +$1.76M |
|
37
EyePoint Pharmaceuticals
EYPT
$827M
| $1.56M | 0.48% |
197,640
+11,974
| +6% | +$94.2K |
|
38
Codexis
CDXS
$218M
| $1.44M | 0.44% |
137,960
+56,960
| +70% | +$596K |
|
39
Nkarta
NKTX
$149M
| $1.37M | 0.42% |
+110,763
| New | +$1.37M |
|
|
AMYT
40
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $1.23M | 0.38% |
176,309
+23,042
| +15% | +$161K |
|
41
Seres Therapeutics
MCRB
$162M
| $1.19M | 0.37% |
347,761
+20,889
| +6% | +$71.6K |
|
|
NGM
42
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $1.13M | 0.35% |
88,303
-112,191
| -56% | -$1.44M |
|
43
Zymeworks
ZYME
$1.07B
| $1.1M | 0.34% |
+208,330
| New | +$1.1M |
|
|
PSTX
44
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $982K | 0.3% |
380,606
+140,910
| +59% | +$364K |
|
45
Celldex Therapeutics
CLDX
$1.57B
| $979K | 0.3% |
36,322
-9,216
| -20% | -$248K |
|
46
ARS Pharmaceuticals
SPRY
$1.08B
| $887K | 0.27% |
+209,108
| New | +$887K |
|
47
PolyPid
PYPD
$54.4M
| $750K | 0.23% |
161,572
-56,603
| -26% | -$263K |
|
48
Stereotaxis
STXS
$246M
| $678K | 0.21% |
368,648
+22,243
| +6% | +$40.9K |
|
|
FMTX
49
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $650K | 0.2% |
94,386
-80,382
| -46% | -$554K |
|
|
CCXI
50
DELISTED
ChemoCentryx, Inc.
CCXI
| $645K | 0.2% |
+26,036
| New | +$645K |
|